Clinical benefit of the gedatolisib regimens was consistent across patient subgroups Hyperglycemia was reported in only 9.2% of patients treated with gedatolisib + palbociclib + fulvestrant ...
Medpage Today on MSN
Another 'Practice-Changing' Study in High-Risk Bladder Cancer
BERLIN -- Adding durvalumab (Imfinzi) to bacillus Calmette-Guérin (BCG) induction and maintenance therapy significantly ...
Dealing with some injuries entering the Week 5 matchup with the Cincinnati Bengals, the Detroit Lions made a couple of practice squad elevations ahead of Sunday's late-afternoon game.
USA TODAY College Sports Wire on MSN
Iowa football comments on injury progression of QB Mark Gronowski
In his Tuesday press conference, Iowa head football coach Kirk Ferentz updated the injury progression with starting ...
MedPage Today on MSN
How Do GLP-1 Drugs Stack Up for Cardiorenal Benefits in Diabetes?
"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...
A 29-year-old man undergoes a total proctocolectomy with end-to-end ileostomy after 2 years of surveillance for ulcerative colitis.
There's a lot more clarity about the Seattle Mariners' pitching after Game 1 of the ALCS. Details on that plus a live BP for ...
The article 🌱 Patch AM: Progressions - 2nd Year Lessons and 10 more events appeared first on Shorewood Patch. Hello ...
Orion Kerkering made a wild throw past home instead of tossing to first after mishandling Andy Pages’ bases-loaded comebacker ...
The five-year invasive disease-free survival (iDFS) rates were 85.5% in the Kisqali plus ET arm versus 81.0% in the ET alone arm, representing a clinically meaningful 4.5% improvement 1. These ...
Giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated populations, respectively, in a post-CDK inhibitor setting, compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results